Induced pluripotent stem cells (iPSCs) have become a cornerstone in regenerative medicine, offering a unique opportunity to generate patient-specific cells for various therapeutic applications. The traditional methods of iPSC production often involve the use of viral vectors, which can pose risks such as insertional mutagenesis and immune responses. Recently, advances in mRNA technology have...